CIK 0000310158
- Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221918501
- Phone
- +1 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President, U.S. Market sold 2,081 shares at $102.38 ($213,061)
- 4 Open-market sale EVP&Pres, Merck Animal Heallth sold 43,823 shares at $105.03 ($4,602,668)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion President, U.S. Market acquired 915 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP, Chief HR Officer sold 4,250 shares at $109.01 ($463,293)
- 4 Exercise or conversion Chief Marketing Officer acquired 36,901 shares (option exercise)
- 4 Open-market sale EVP, Chief HR Officer sold 4,500 shares at $105.49 ($474,701)
- 4 Open-market sale President, Human Health Int?l sold 89 shares at $107.37 ($9,556)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President, Human Health Int?l bought 409 shares at an average $108.40 ($44,336)
- 4 Derivatives Options or other derivatives
Page 12 of 99 · 1,973 filings